Gallotta, Valerio
 Distribuzione geografica
Continente #
NA - Nord America 4.918
AS - Asia 4.023
EU - Europa 3.987
SA - Sud America 880
AF - Africa 102
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.926
Nazione #
US - Stati Uniti d'America 4.799
SG - Singapore 1.878
DE - Germania 1.106
CN - Cina 902
BR - Brasile 714
SE - Svezia 693
IT - Italia 455
FR - Francia 393
VN - Vietnam 393
PL - Polonia 335
IN - India 213
GB - Regno Unito 200
UA - Ucraina 191
IE - Irlanda 182
FI - Finlandia 122
ID - Indonesia 117
JP - Giappone 111
RU - Federazione Russa 96
HK - Hong Kong 95
AR - Argentina 55
IQ - Iraq 50
TR - Turchia 49
CA - Canada 48
MX - Messico 43
BD - Bangladesh 37
BE - Belgio 34
ES - Italia 34
NL - Olanda 34
EC - Ecuador 31
ZA - Sudafrica 29
PK - Pakistan 21
IR - Iran 17
RO - Romania 17
VE - Venezuela 17
AT - Austria 16
CL - Cile 16
KE - Kenya 16
KR - Corea 16
UZ - Uzbekistan 15
SA - Arabia Saudita 14
CO - Colombia 13
JO - Giordania 13
CZ - Repubblica Ceca 12
MA - Marocco 12
CH - Svizzera 11
CI - Costa d'Avorio 11
EG - Egitto 10
PE - Perù 10
PY - Paraguay 10
GR - Grecia 9
IL - Israele 9
AU - Australia 8
KZ - Kazakistan 8
MY - Malesia 8
LT - Lituania 7
PH - Filippine 7
BO - Bolivia 6
JM - Giamaica 6
PA - Panama 6
TN - Tunisia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BH - Bahrain 5
DK - Danimarca 5
ET - Etiopia 5
HU - Ungheria 5
LV - Lettonia 5
NP - Nepal 5
AZ - Azerbaigian 4
KG - Kirghizistan 4
LB - Libano 4
MN - Mongolia 4
NZ - Nuova Zelanda 4
TT - Trinidad e Tobago 4
AL - Albania 3
BN - Brunei Darussalam 3
HR - Croazia 3
LK - Sri Lanka 3
MD - Moldavia 3
NG - Nigeria 3
OM - Oman 3
PT - Portogallo 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BY - Bielorussia 2
BZ - Belize 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GF - Guiana Francese 2
HN - Honduras 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
SN - Senegal 2
TH - Thailandia 2
TW - Taiwan 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BS - Bahamas 1
Totale 13.908
Città #
Singapore 1.053
Chandler 847
San Jose 529
Ashburn 452
Warsaw 310
Beijing 198
Dublin 176
New York 142
Ho Chi Minh City 137
San Mateo 131
Ann Arbor 117
Jacksonville 115
Lauterbourg 111
Los Angeles 107
Jakarta 104
Hanoi 100
Tokyo 97
Boston 89
Wilmington 88
Frankfurt am Main 85
Nanjing 85
Hong Kong 75
Rome 74
Nürnberg 71
Houston 70
Dearborn 69
São Paulo 66
Marseille 65
Hefei 61
Princeton 61
Hyderabad 60
Helsinki 58
Cattolica 54
Moscow 53
Redwood City 45
Munich 44
Woodbridge 44
The Dalles 43
Dallas 42
Milan 42
Fairfield 40
Fuzhou 36
Brussels 34
Chicago 34
Santa Clara 34
Lawrence 32
Seattle 31
Buffalo 30
Orem 29
Nanchang 28
Kunming 25
St Louis 25
Hangzhou 22
Rio de Janeiro 22
Augusta 21
London 21
Turku 21
Boardman 20
Mountain View 20
Atlanta 19
Belo Horizonte 19
Changsha 19
Da Nang 19
Johannesburg 19
Norwalk 19
Shanghai 19
Leawood 18
Shenyang 18
Tianjin 18
Düsseldorf 17
Mumbai 17
Amsterdam 16
Baghdad 16
Bremen 16
Council Bluffs 16
Hebei 16
Lancaster 16
Seoul 16
Chennai 15
Dhaka 15
Roubaix 15
San Francisco 15
Brooklyn 14
Paris 14
Poplar 14
Quito 14
Denver 13
Haiphong 13
Izmir 13
Jiaxing 13
Kent 13
Mexico City 13
Nairobi 13
Nuremberg 13
Stockholm 13
Tashkent 13
Toronto 13
Salvador 12
Zhengzhou 12
Abidjan 11
Totale 7.322
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 865
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 374
A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer. 290
Elderly and very elderly advanced ovarian cancer patients: Does the age influence the surgical management? 288
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 228
Total laparoscopic hysterectomy in early-stage endometrial cancer using an intrauterine manipulator: is it a bias for frozen section analysis? Case-control study 220
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 209
Secondary cytoreductive surgery in patients with isolated platinum-resistant recurrent ovarian cancer: A retrospective analysis 188
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 188
Urologic surgery in gynecologic oncology: a large single-institution experience 183
Laparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomes 182
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 182
Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery 178
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 177
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 171
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 171
Teaching and training in laparoscopic surgery: experience of Catholic Laparoscopy Advanced Surgery School in the basic gynecological surgery 168
Airway Closure during Surgical Pneumoperitoneum in Obese Patients 156
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 154
From palliation to cure: PIPAC for peritoneal malignancies 151
Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study 150
Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series 149
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 147
Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature 144
Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer 142
Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients. 141
Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery Versus Standard Laparotomic Treatment: From Body to Mind and Back 138
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer 136
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 136
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases 134
Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients 134
Perioperative outcomes of laparoendoscopic single-site surgery (LESS) versus conventional laparoscopy for adnexal disease: a case--control study 133
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 132
Douglas peritonectomy compared to recto-sigmoid resection in optimally cytoreduced advanced ovarian cancer patients: analysis of morbidity and oncological outcome 131
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 131
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 130
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 129
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 129
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): A feasibility study 128
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 128
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 126
Peritoneal Hpv-Dna Test In Cervical Cancer (Pioneer Study): A Proof Of Concept 124
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 123
The role of robotic aortic lymphadenectomy in gynecological cancer: surgical and oncological outcome in a single institution experience 123
Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series 122
Minimally invasive versus open pelvic exenteration in gynecological malignancies: A propensity-matched survival analysis 121
The new robotic TELELAP ALF-X in gynecological surgery: single-center experience 121
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 121
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 121
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 121
Can We Define the Risk of Lymph Node Metastasis in Early-Stage Cervical Cancer Patients? A Large-Scale, Retrospective Study 118
Role of Intraoperative Ultrasound to Extend the Application of Minimally Invasive Surgery for Treatment of Recurrent Gynecologic Cancer 118
Predictive factors of surgical complications after pelvic exenteration for gynecological malignancies: a large single-institution experience 117
Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study 117
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 116
Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach 116
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control Study 115
Lung-protective ventilation during Trendelenburg pneumoperitoneum surgery: A randomized clinical trial 114
Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study 113
Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach 113
Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? 112
Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis 112
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 111
Robotic Versus Laparoscopic Staging for Early Ovarian Cancer: A Case Matched Control Study 111
A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial 111
Can the Modified Frailty Index (mFI) Predict Intraoperative and Postoperative Complications in Older Women with Endometrial Cancer Undergoing Laparoscopic or Robotic Surgery? A Multicenter Observational Study 110
Technological innovation and personalized surgical treatment for early-stage endometrial cancer patients: A prospective multicenter Italian experience to evaluate the novel percutaneous approach 110
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer 109
Radical hysterectomy after chemoradiation in FIGO stage III cervical cancer patients versus chemoradiation and brachytherapy: Complications and 3-years survival 109
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 107
Upper abdominal surgery in advanced and recurrent ovarian cancer: role of diaphragmatic surgery 105
Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience 105
Krukenberg tumors: Seed, route and soil 104
Prognostic factors for survival in patients with lung metastases from gynaecological tract cancers 104
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience 103
Pathological features, immunoprofile and mismatch repair protein expression status in uterine endometrioid carcinoma: focus on MELF pattern of myoinvasion 103
Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: Our experience 100
Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection 99
Robotic Secondary Cytoreduction with 3D Reconstruction for Isolated Recurrent Ovarian Cancer: A Stepwise Approach to Splenectomy 98
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs 98
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 98
Secondary cytoreduction in ovarian cancer: who really benefits? 98
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 95
Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies 95
Minimally invasive secondary cytoreductive surgery for hepato-renal recess isolated recurrence of serous endometrial cancer in BRCA1 mutated patient 95
STOMA study SToma-leak ratio in advanced ovarian cancer surgery: Results of a restrictive policy on the use of protective stoMAs 94
Minimally invasive surgical staging for early stage ovarian cancer: A long-term follow up 94
Enhanced recovery after surgery (ERAS) in gynecology oncology 93
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 90
Total laparoendoscopic single-site surgery (LESS) hysterectomy in low-risk early endometrial cancer: a pilot study 89
Role of robotic surgery in ovarian malignancy 88
Laparoscopy vs. Laparotomy for advanced ovarian cancer: A systematic review of the literature 88
Surgery after upfront chemoradiation in locally advanced squamous cell vulvar cancer: Analysis of postoperative outcomes and survival 85
Robotic Single-Port Platform in General, Urologic, and Gynecologic Surgeries: A Systematic Review of the Literature and Meta-analysis 85
Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery 85
Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study 84
Dose-dense paclitaxel/carboplatin as neo-adjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer: a prospective phase II study 83
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 83
ASO Author Reflections: Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery-What We Know and Future Perspectives 82
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer 81
Totale 13.731
Categoria #
all - tutte 55.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021178 0 0 0 0 0 0 0 0 0 0 146 32
2021/20221.057 88 43 15 135 38 20 23 137 40 81 201 236
2022/20232.107 337 301 175 322 120 265 97 134 246 20 51 39
2023/2024882 28 279 16 88 24 115 56 40 12 27 99 98
2024/20251.928 44 45 132 66 144 86 80 75 282 228 403 343
2025/20265.242 801 191 312 656 959 362 863 295 356 416 31 0
Totale 14.637